Hana Pharm Co., Ltd. (KRX:293480)
South Korea · Delayed Price · Currency is KRW 11,380
-80 (-0.70%)
At close: Nov 21, 2025
Hana Pharm Market Cap
Hana Pharm has a market cap or net worth of 204.39 billion as of November 26, 2025. Its market cap has increased by 3.79% in one year.
Market Cap
204.39B
Enterprise Value
n/a
Revenue
139.33B
Ranking
n/a
PE Ratio
5.13
Stock Price
11,380.00
Market Cap Chart
Since October 2, 2018, Hana Pharm's market cap has decreased from 537.03B to 204.39B, a decrease of -61.94%. That is a compound annual growth rate of -12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 204.39B | 5.50% |
| Dec 30, 2024 | 193.73B | -21.86% |
| Dec 28, 2023 | 247.93B | -23.56% |
| Dec 29, 2022 | 324.36B | -9.43% |
| Dec 30, 2021 | 358.12B | -14.15% |
| Dec 30, 2020 | 417.15B | 14.19% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.81T |
| Celltrion | 39.84T |
| ALTEOGEN | 28.19T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.54T |
| Peptron | 8.60T |
| Yuhan | 8.60T |
| LigaChem Biosciences | 6.25T |